Literature DB >> 15358183

Afadin- and alpha-actinin-binding protein ADIP directly binds beta'-COP, a subunit of the coatomer complex.

Masanori Asada1, Kenji Irie, Akio Yamada, Yoshimi Takai.   

Abstract

Afadin DIL domain-interacting protein (ADIP) is a novel protein that binds both afadin and alpha-actinin and localizes at adherens junctions, which are formed by nectins and cadherins, cell-cell adhesion molecules. Afadin is an actin filament (F-actin)-binding protein which connects nectins to the actin cytoskeleton. alpha-Actinin is another F-actin-binding protein that is indirectly associated with cadherins through the catenin complex. ADIP is at least partly involved in the physical association of nectins and cadherins. We show here that ADIP furthermore binds beta'-COP, a subunit of the coatomer complex. ADIP co-localizes with beta'-COP at the Golgi complex in Madin Darby canine kidney and normal rat kidney cells. These results suggest that ADIP is involved in vesicle trafficking from the Golgi to the endoplasmic reticulum and through the Golgi complex by interacting with the coatomer complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358183     DOI: 10.1016/j.bbrc.2004.06.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

2.  Orientia tsutsugamushi Ank9 is a multifunctional effector that utilizes a novel GRIP-like Golgi localization domain for Golgi-to-endoplasmic reticulum trafficking and interacts with host COPB2.

Authors:  Andrea R Beyer; Kyle G Rodino; Lauren VieBrock; Ryan S Green; Brittney K Tegels; Lee D Oliver; Richard T Marconi; Jason A Carlyon
Journal:  Cell Microbiol       Date:  2017-02-03       Impact factor: 3.715

3.  SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma.

Authors:  Pu Li; Ying Lin; Yu Zhang; Zhenggang Zhu; Keke Huo
Journal:  J Transl Med       Date:  2013-03-01       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.